NasdaqGS:BIIBBiotechs
Has The Market Overlooked Biogen (BIIB) After A 62% One Year Share Price Jump
If you are wondering whether Biogen's current share price lines up with its underlying value, the recent performance gives you plenty to think about.
The stock closed at US$189.13 recently, with returns of 3.1% over 7 days, 6.6% over 30 days, 6.4% year to date and 61.9% over the past year. The 3 year and 5 year returns sit at 39.8% and 32.1% declines respectively.
These moves come as Biogen stays in focus in the large cap biotech space, with ongoing attention on its pipeline and portfolio...